MyFinsight
Home
Blog
About
Contact
Back
Income Statement
Silence Therapeutics plc (SLN)
Silence Therapeutics plc (SLN)
source: myfinsight.com
Download
Download image
Net loss
-$14,957K
(47.57%↑ Y/Y)
Loss before income
tax expense
-$14,957K
Benefit from r&d credit
$691K
Other income, net
$571K
Revenue
$422K
(197.18%↑ Y/Y)
Operating loss
-$15,737K
Gross profit
$411K
Foreign currency
gain/(loss), net
-$482K
Cost of sales
$11K
(-79.63%↓ Y/Y)
Research and development
costs
$9,122K
General and
administrative expenses
$7,026K
(-8.56%↓ Y/Y)
Back